Page last updated: 2024-10-22

albuterol and Spinal Muscular Atrophies of Childhood

albuterol has been researched along with Spinal Muscular Atrophies of Childhood in 3 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Spinal Muscular Atrophies of Childhood: A group of recessive inherited diseases that feature progressive muscular atrophy and hypotonia. They are classified as type I (Werdnig-Hoffman disease), type II (intermediate form), and type III (Kugelberg-Welander disease). Type I is fatal in infancy, type II has a late infantile onset and is associated with survival into the second or third decade. Type III has its onset in childhood, and is slowly progressive. (J Med Genet 1996 Apr:33(4):281-3)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frongia, AL1
Natera-de Benito, D1
Ortez, C1
Alarcón, M1
Borrás, A1
Medina, J1
Vigo, M1
Padrós, N1
Moya, O1
Armas, J1
Carrera-García, L1
Expósito-Escudero, J1
Cuadras, D1
Bernal, S1
Martorell, L1
Colomer, J1
Nascimento, A1
Pane, M1
Staccioli, S1
Messina, S1
D'Amico, A1
Pelliccioni, M1
Mazzone, ES1
Cuttini, M1
Alfieri, P1
Battini, R1
Main, M2
Muntoni, F2
Bertini, E1
Villanova, M1
Mercuri, E2
Kinali, M1
De Biasia, F1
Karatza, A1
Higgins, R1
Banks, LM1
Manzur, AY1

Trials

2 trials available for albuterol and Spinal Muscular Atrophies of Childhood

ArticleYear
Daily salbutamol in young patients with SMA type II.
    Neuromuscular disorders : NMD, 2008, Volume: 18, Issue:7

    Topics: Adrenergic beta-Agonists; Albuterol; Child; Child, Preschool; Cohort Studies; Electrocardiography; F

2008
Pilot trial of albuterol in spinal muscular atrophy.
    Neurology, 2002, Aug-27, Volume: 59, Issue:4

    Topics: Absorptiometry, Photon; Adrenergic beta-Agonists; Albuterol; Blood Pressure; Body Composition; Child

2002

Other Studies

1 other study available for albuterol and Spinal Muscular Atrophies of Childhood

ArticleYear
Salbutamol tolerability and efficacy in patients with spinal muscular atrophy type II.
    Neuromuscular disorders : NMD, 2019, Volume: 29, Issue:7

    Topics: Adolescent; Adrenergic beta-Agonists; Age of Onset; Albuterol; Child; Child, Preschool; Female; Hosp

2019